Is "Beta Cell Rest" by Insulin Treatment Beneficial Compared to State-of-the Art Enhancers of Insulin Secretion in Preserving Beta Cell Function in Subjects With Latent Autoimmune Diabetes of the Adult (LADA).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 25 Aug 2017
At a glance
- Drugs Insulin suspension isophane (Primary) ; Metformin; Repaglinide; Sitagliptin
- Indications Latent autoimmune diabetes in adults
- Focus Therapeutic Use
- 18 Aug 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2018.
- 18 Aug 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2018.
- 10 Jun 2017 Biomarkers information updated